Navigation Links
Total darkness at night is key to success of breast cancer therapy -- Tulane study
Date:7/24/2014

Exposure to light at night, which shuts off nighttime production of the hormone melatonin, renders breast cancer completely resistant to tamoxifen, a widely used breast cancer drug, says a new study by Tulane University School of Medicine cancer researchers. The study, "Circadian and Melatonin Disruption by Exposure to Light at Night Drives Intrinsic Resistance to Tamoxifen Therapy in Breast Cancer," published in the journal Cancer Research, is the first to show that melatonin is vital to the success of tamoxifen in treating breast cancer.

Principal investigators and co-leaders of Tulane's Circadian Cancer Biology Group, Steven Hill and David Blask, along with team members Robert Dauchy and Shulin Xiang, investigated the role of melatonin on the effectiveness of tamoxifen in combating human breast cancer cells implanted in rats.

"In the first phase of the study, we kept animals in a daily light/dark cycle of 12 hours of light followed by 12 hours of total darkness (melatonin is elevated during the dark phase) for several weeks," says Hill. "In the second study, we exposed them to the same daily light/dark cycle; however, during the 12 hour dark phase, animals were exposed to extremely dim light at night (melatonin levels are suppressed), roughly equivalent to faint light coming under a door."

Melatonin by itself delayed the formation of tumors and significantly slowed their growth but tamoxifen caused a dramatic regression of tumors in animals with either high nighttime levels of melatonin during complete darkness or those receiving melatonin supplementation during dim light at night exposure.

These findings have potentially enormous implications for women being treated with tamoxifen and also regularly exposed to light at night due to sleep problems, working night shifts or exposed to light from computer and TV screens.

"High melatonin levels at night put breast cancer cells to 'sleep' by turning off key growt
'/>"/>

Contact: Arthur Nead
anead@tulane.edu
504-247-1443
Tulane University
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. NIH scientists take totally tubular journey through brain cells
2. Obesity associated with longer hospital stays, higher costs in total knee replacement patients
3. Patients with metabolic disorder may face higher complication risk following total joint replacement
4. Total hip replacement surgery safe for nonagenarian patients
5. Total Balance Men’s: Review Released for Xtend-Life’s Comprehensive Dietary Supplement for Men
6. Extreme Makeover Home Edition Star John Littlefield Discussed His Experiences on The Show on The Total Education Celebrity Show, a Division of The Simply G Media Network
7. OrthAlign, Inc. Announces Milestone in 13,500th KneeAlign® Total Knee Arthroplasty Case
8. Total Wellness Cleanse Review
9. How This Program Helps People Detox Their Body Naturally – HealthReviewCenter
10. Total Body Cleanse and Detox Tips to Improve Health and Wellness Released by Detox Dieter
11. Total Wellness Cleanse Review Released by Detox Dieter
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Total darkness at night is key to success of breast cancer therapy -- Tulane study
(Date:9/1/2015)... ... 2015 , ... Ogawa’s new massage chairs tout innovative functionality that change the ... ever before. With the goal of bringing wellness to the world, Ogawa introduces their ... , As in its name, the Ogawa Refresh aims to “refresh” and ...
(Date:9/1/2015)... NV (PRWEB) , ... September 01, 2015 , ... ... or Self-Directed Care is, how to access caregivers and what to look for ... valuable and pertinent information. , Founded in 2006 in Canoga Park, CA by ...
(Date:9/1/2015)... Pasadena, California (PRWEB) , ... September 01, 2015 ... ... Anna Arrowsmith interviewed dating men and pick-up artists about their experiences of female ... alongside men’s bodily concerns, including penis issues, as well as their relationships with ...
(Date:9/1/2015)... ... 01, 2015 , ... MediNatura™, the exclusive U.S. importer of ... assistants (PAs) practicing in orthopedics. The workshop, titled “Treatment of Osteoarthritis Knee Pain ... Salado, an orthopedic surgeon at South Florida Bone and Joint Institute, Inc. The ...
(Date:8/31/2015)... ... September 01, 2015 , ... AthleticTraining.com, provider ... of ten hours of new premium on-demand video Evidence Based Practice ... Trainers certified before 2014 must complete 50 CEUs before December 31, 2015, which ...
Breaking Medicine News(10 mins):Health News:Ogawa World USA Releases New Massage Chairs to the US 2Health News:Ogawa World USA Releases New Massage Chairs to the US 3Health News:AdvantagePlusCaregivers.com® Launches New Website for Corporate and Franchisee Locations in 3 States 2Health News:Female Porn Director Explains Male Insecurities about Women in a New Book 2Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 2Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 3Health News:Evidence Based Practice Courses: CEUs For Athletic Trainers Just Released 2
... surgeon has put forth the idea that it would do ... had earlier been opposed and led to the// removal of ... Canterbury District Health Board had removed the patients from waiting ... with the Health ministry policy. Nearly Seventy-four of the DHB's ...
... suffer from sunburn could stand to benefit immensely from a ... skin and can protect against skin// cancer. This research is ... ,The new component of the sunscreen lotion works by ... is released when the skin burns. This is quite unlike ...
... cervical cancer has been called for by the Well Woman Centre.// ... that a vaccine against cervical cancer is expected to be available ... hailed the development of the vaccine, Gardasil, as one of the ... of the vaccine were disclosed at a medical conference in Prague ...
... that can often be disabling and one of the ... could mainly be due to their genetic// inheritance. ... of Psychological Medicine), in a genetic study of twins, ... together, they are of different genetic and environmental causes. ...
... breakthrough, towards the testing and cure for the pregnancy ... National Institutes of Health team found women with pre-eclampsia ... developing the condition. Reporting their findings they explained that ... responsible for virtually all cases of pre-eclampsia, which is ...
... U.N. children's agency, UNICEF and the Barcelona soccer club announced ... donate $1.9 million a year over the next five// years ... ,Their first installment will go towards the AIDS ... where around 40 percent of adults are infected with HIV, ...
Cached Medicine News:Health News:Key component of sunscreen heals sunburn and prevents skin cancer 2Health News:Key component of sunscreen heals sunburn and prevents skin cancer 3Health News:Placental Proteins Could Be Responsible For Pre-eclampsia 2
(Date:8/31/2015)... STAMFORD, Conn. , Aug. 31, 2015 /PRNewswire/ ... Ltd., and Purdue Pharma L.P. announced today that they ... development and commercialization of Eisai,s clinical candidate lemborexant (development ... III clinical development for the treatment of insomnia. ... and Purdue Pharma will share the costs of lemborexant ...
(Date:8/31/2015)... 2015 Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical ... therapeutics for the treatment of diseases of the central ... BNC101 IND submission has passed review by the US ... a Phase 1 clinical trial in patients with metastatic ... prior to 31 December 2015. Bionomics, CEO ...
(Date:8/31/2015)... , Aug. 31, 2015 Research ... addition of the "Prescription Pain Drugs - ... Marijuana - Global Markets, Competitors and Opportunities: 2015 ... their offering. Pain is defined ... with actual or potential tissue damage. At some ...
Breaking Medicine Technology:Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3
... DIEGO, Jan. 7, 2011 ADVENTRX Pharmaceuticals, Inc. (NYSE ... has entered into definitive agreements to sell 8,184,556 units ... certain healthcare-focused investors, and other institutional investors for a ... to ADVENTRX of approximately $22.5 million.  Each unit consists ...
... Jan. 7, 2011 WaferGen Biosystems, Inc. (OTC Bulletin ... state-of-the-art genomic analysis systems, today announced that it will ... Annual OneMedForum Business Development and Investment Conference for emerging ... JP Morgan Healthcare Conference in San Francisco, January 11-13, ...
Cached Medicine Technology:ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million 2ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million 3WaferGen to Present at OneMedForum San Francisco 2011 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: